Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Current Opinion in Gastroenterology|March 18, 2021
Positioning biologics and small molecules in the management of moderate to severe ulcerative colitisBincy Abraham, Kerri GlassnerInflammatory Bowel Diseases|May 17, 2017
Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel DiseaseKerri Glassner, Hoda M Malaty, Bincy P AbrahamClinical and Experimental Gastroenterology|November 12, 2024
Therapeutic Potential of Etrasimod in the Management of Moderately-to-Severely Active Ulcerative Colitis: Evidence to DateKerri Glassner, Christopher Fan, Malcolm Irani, et al.Clinical and Experimental Gastroenterology|March 14, 2023
Clinical Evaluation of Upadacitinib in the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis (UC): Patient Selection and Reported OutcomesMalcolm Irani, Christopher Fan, Kerri Glassner, et al.AIMS Microbiology|July 12, 2019
Autoimmune liver disease and the enteric microbiomeKerri Glassner, Eamonn Mm Quigley, Lissa Franco, et al.Biologics : Targets & Therapy|June 24, 2022
Biological Therapies for the Management of Enteric Disease: Considerations for the ClinicianAdam Saleh, Usman Ansari, Shaadi Abughazaleh, et al.Journal of Digestive Diseases|April 8, 2024
Therapeutic drug monitoring in patients with inflammatory bowel disease on ustekinumabAdam Saleh, Rachel Stading, Natalia Miroballi, et al.Digestive Diseases and Sciences|March 17, 2023
Patient Attitudes and Barriers to Endoscopy During the COVID-19 PandemicGulchin A Ergun, Shaadi Abughazaleh, Kerri Glassner, et al.ACG Case Reports Journal|December 18, 2023
Development of Shingles on Tofacitinib Despite Completion of Recombinant Varicella-Zoster Virus Vaccine SeriesBraden Thomas, Joshua Moskow, Manuel Garza, et al.Digestive Diseases and Sciences|May 24, 2024
Postoperative Ustekinumab Drug Levels and Disease Activity in Patients with Crohn's DiseaseJoshua Moskow, Theresa Thurston, Adam Saleh, et al.Pageof 2